Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis.
Petrelli F, Ferrara R, Signorelli D, Ghidini A, Proto C, Roudi R, Sabet MN, Facelli S, Garassino MC, Luciani A, Roviello G.
Petrelli F, et al. Among authors: roudi r.
Immunotherapy. 2021 May;13(7):621-631. doi: 10.2217/imt-2020-0224. Epub 2021 Mar 29.
Immunotherapy. 2021.
PMID: 33775103